• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . CT screening for COVID-19 in asymptomatic patients before hospital admission

tetano

Editor, Senior Moderator
J Infect Chemother


. 2020 Sep 29;S1341-321X(20)30345-7.
doi: 10.1016/j.jiac.2020.09.025. Online ahead of print.
CT screening for COVID-19 in asymptomatic patients before hospital admission


Sho Uchida[SUP] 1 [/SUP], Shunsuke Uno[SUP] 1 [/SUP], Yoshifumi Uwamino[SUP] 2 [/SUP], Masahiro Hashimoto[SUP] 3 [/SUP], Shunsuke Matsumoto[SUP] 3 [/SUP], Hideaki Obara[SUP] 4 [/SUP], Masahiro Jinzaki[SUP] 3 [/SUP], Yuko Kitagawa[SUP] 4 [/SUP], Naoki Hasegawa[SUP] 5 [/SUP], Keio Donner Project Team



Affiliations

Abstract

Introduction: In the novel coronavirus disease (COVID-19) pandemic era, it is essential to rule out COVID-19 effectively to prevent transmission in both communities and medical facilities. According to previous reports in high prevalence areas, CT screening may be useful in the diagnosis of COVID-19. However, the value of CT screening in low prevalence areas has scarcely been reported.
Methods: This report examines the diagnostic efficacy of CT screening before admission to a hospital in Tokyo. We conducted a retrospective analysis at Keio University Hospital from April 6, 2020, through May 29, 2020. We set up an outpatient screening clinic on April 6 for COVID-19, administering both PCR with nasopharyngeal swabs and chest CT for all patients scheduled for surgery under general anesthesia.
Results: A total of 292 asymptomatic patients were included in this study. There were three PCR-positive patients, and they all had negative CT findings, which revealed that both the sensitivity and positive predictive value of CT (PPV) were 0%. There were nine CT-positive patients; the specificity and the negative predictive value (NPV) were 96.9% and 98.9%, respectively.
Conclusion: CT screening was not useful in low prevalence areas at this time in Tokyo, even with the inclusion of the most prevalent phase. Given that the utility of CT screening depends on disease prevalence, the criteria for performing CT screening based on the prevalence of COVID-19 should be established.

Keywords: Asymptomatic; COVID-19; CT; Screening.
 
Back
Top Bottom